Home | Resources

Resources

Featured image for titled Development, Validation, and Implementation of an Augmented Multiwell, Multitarget Quantitative PCR for the Analysis of Human Papillomavirus Genotyping through Software Automation, Data Science, and Artificial Intelligence

Velsera Publications

On July 5, 2024 | By The Velsera Clinical and Compliance Team

Development, Validation, and Implementation of an Augmented Multiwell, Multitarget Quantitative PCR for the Analysis of Human Papillomavirus Genotyping through Software Automation, Data Science, and Artificial Intelligence

Read more
Featured image for titled Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey

News

On June 28, 2024 | By The Velsera Clinical and Compliance Team

Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey

Read more
Featured image for titled Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus

News

On June 27, 2024 | By The Velsera Clinical and Compliance Team

Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus

Read more
Featured image for titled Navigating your molecular lab’s test selection and development over the next two years

Blog

On June 20, 2024 | By The Velsera Clinical and Compliance Team

Navigating your molecular lab’s test selection and development over the next two years

Read more
Featured image for titled Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show

News

On June 3, 2024 | By The Velsera Clinical and Compliance Team

Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show

Read more
Featured image for titled Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline

Blog

On May 21, 2024 | By Bojana Smiljanic

Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline

Read more
Featured image for titled Four Years, Five Stages: the FDA’s Final Rule on LDTs

Blog

On May 14, 2024 | By The Velsera Clinical and Compliance Team

Four Years, Five Stages: the FDA’s Final Rule on LDTs

Read more
Featured image for titled Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research

News

On April 4, 2024 | By The Velsera Clinical and Compliance Team

Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research

Read more
Featured image for titled Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data

Video

On April 3, 2024 | By The Velsera Clinical and Compliance Team

Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data

Read more
Featured image for titled Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer

News

On March 5, 2024 | By The Velsera Clinical and Compliance Team

Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer

Read more
Featured image for titled State of the Union: NGS Reimbursement

Video

On February 29, 2024 | By The Velsera Clinical and Compliance Team

State of the Union: NGS Reimbursement

Read more
Featured image for titled Faster, smarter clinical interpretation workflows unveiled on CGW platform

News

On November 15, 2023 | By The Velsera Clinical and Compliance Team

Faster, smarter clinical interpretation workflows unveiled on CGW platform

Read more
1 2 3 4 5 6